マルチプレックスアッセイ市場：タイプ別（タンパク質ベースマルチプレックスアッセイ、核酸ベースマルチプレックスアッセイ、その他マルチプレックスアッセイ）、製品別（試薬・消耗品、機器・アクセサリー、ソフトウェア・サービス）、用途別（臨床診断、研究・開発、コンパニオン診断）、エンドユーザー（病院、臨床研究所、研究機関、医薬品・バイオテクノロジー企業）。世界の市場機会分析および産業予測、2020-2030年

Multiplex Assay Market by Type (Protein Based Multiplex Assays, Nucleic Acid-Based Multiplex Assay, and Other Multiplex Assays), Product (Reagents & Consumables, Instruments & Accessories, and Software & Services), Application (Clinical Diagnostics, Research & Development, and Companion Diagnostics), and End User (Hospitals, Clinical Laboratories, Research Institutes, And Pharmaceutical & Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2020–2030

マルチプレックスアッセイの世界市場は、2020年には19億4049万ドルで、2021年から2030年までのCAGRは8.3%を記録し、2030年には43億6632万ドルに達すると予測されています。マルチプレックスアッセイは、様々な... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年1月24日	US$6,168 シングルユーザーライセンスライセンス・価格情報注文方法はこちら	245	英語

サマリー

マルチプレックスアッセイの世界市場は、2020年には19億4049万ドルで、2021年から2030年までのCAGRは8.3%を記録し、2030年には43億6632万ドルに達すると予測されています。
マルチプレックスアッセイは、様々な分析物（タンパク質、生体分子、成長因子、サイトカイン、ケモカインなど）を同時に検出・定量化することでプロファイリングする手法です。このアッセイは、ポリメラーゼ連鎖反応（PCR）で複数の標的を増幅し、ELISAなどの従来の方法と比較して、微量のタンパク質やその他の分析物から短時間で多くの情報を収集するために使用されます。マルチプレックスアッセイは、病原体の同定、変異解析、RNA検出、遺伝子検出解析、連鎖解析、法医学研究などに広く利用されています。
マルチプレックスアッセイ市場は、いくつかの疾患の治療のための医薬品の研究開発活動の増加により、著しい成長を遂げています。これらのアッセイは、研究コストや手作業を減らし、実験や治療の効率を高めるため、臨床試験で使用されています。さらに、従来の方法と比較して、疾患の分析が容易かつ迅速に行えることや、自動化されていることも、市場の成長に拍車をかけています。しかし、高い設備投資と熟練労働者の不足が、市場成長を阻害する主な要因となっています。

本レポートでは、マルチプレックスアッセイの世界市場を、タイプ、製品、用途、エンドユーザー、地域に基づいて調査しています。タイプに基づいて、市場はタンパク質ベースのマルチプレックスアッセイ、核酸ベースのマルチプレックスアッセイ、およびその他のマルチプレックスアッセイに分けられます。製品別では、試薬・消耗品、機器・付属品、ソフトウェア・サービスに分類されます。
また、対象となるアプリケーションには、臨床診断、研究開発、コンパニオン診断が含まれます。エンドユーザー別では、病院、臨床検査室、研究機関、製薬・バイオテクノロジー企業などに分類されます。地域別では、北米、欧州、アジア太平洋地域、LAMEAで分析されています。
市場を牽引する主な要因は、コンパニオン診断におけるマルチプレックスアッセイの利用拡大、シングルプレックスや従来のアッセイに対する優位性の向上、慢性疾患や感染症の発生率の増加、疾患の早期診断に関する意識の高まりです。さらに、個別化医療の採用拡大、従来のアッセイに対するマルチプレックスアッセイの幅広い利点が、マルチプレックスアッセイ市場の成長にプラスの影響を及ぼしています。
しかし、熟練した専門家の不足がマルチプレックスアッセイ市場の成長の妨げになることが予想されます。さらに、マルチプレックスアッセイ装置の面倒で複雑な性質に加え、高い調達コストと運用コストが、マルチプレックスアッセイ市場の大きなハードルとして残っています。
分子およびタンパク質診断におけるバイオマーカーの検証の増加、ハイスループットおよび自動化システムのニーズの高まりは、マルチプレックスアッセイ市場に有利な機会を作り出しています。
地域別では、北米、欧州、アジア太平洋地域、LAMEAで分析されています。北米は、2020年のマルチプレックスアッセイ市場で最大の市場シェアを占め、予測期間中もその優位性を維持すると予測されています。これは主に、新しいバイオマーカーの検出のための政府資金の増加、新薬や診断・治療オプションの研究開発活動の活発化、およびがんや脳卒中などの慢性疾患の有病率の急増に起因するものである。
世界のマルチプレックスアッセイ市場で事業を展開している主要企業は、Luminex Corporation、Thermo Fisher Scientific Inc.、Illumina Inc.、Bio-Rad Laboratories Inc.、QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc, Meso Scale Diagnostics LLC、Randox Laboratories Ltd.などです。これらのプレイヤーは、主要な開発戦略として、製品の発売、コラボレーション、およびM&Aを採用しました。
ステークホルダーにとっての主なメリット
- 本レポートは、世界のマルチプレックスアッセイ市場規模を現在の動向と将来予測とともに詳細に分析し、差し迫った投資ポケットを解明するものです。
- 2021年から2030年までの市場分析を提供しており、利害関係者が市場に存在する機会を活用することを可能にすると期待されます。
- 地域に関する包括的な分析は、地域市場を理解し、戦略的な事業計画を促進し、優勢な機会を決定するのに役立ちます。
- 主要企業のプロファイルと成長戦略を徹底的に分析し、マルチプレックスアッセイの世界市場成長の競争展望を理解します。

主要な市場セグメント
# タイプ別
##タンパク質ベースマルチプレックスアッセイ
##核酸ベースマルチプレックスアッセイ
#その他のマルチプレックスアッセイ

# 製品別
##試薬・消耗品
##装置および付属品
##ソフトウェアとサービス

#アプリケーション別
##臨床診断薬
##研究開発
##コンパニオン診断薬

#エンドユーザー別
##病院
#臨床検査室
##研究機関
##製薬・バイオテクノロジー企業

#地域別
##北米
###米国
###カナダ
###メキシコ
##ヨーロッパ
###ドイツ
###フランス
###イギリス
###イタリア
###スペイン
###その他のヨーロッパ
##アジア太平洋
###日本
###中国
###オーストラリア
###インド
###韓国
###その他のアジア太平洋地域
#ラメア
###ブラジル
###サウジアラビア
###南アフリカ
###LAMEAの残りの地域

報告書に掲載されている主要企業の一覧です。
- ルミネックスコーポレーション
- サーモフィッシャーサイエンティフィック社
- イルミナ・インク
- バイオ・ラッド・ラボラトリーズ・インク
- QIAGEN N.V.
- ベクトン・ディッキンソンアンドカンパニー
- アブカムPLC
- シージーン社
- メソスケールダイアグノスティックスLLC
- ランドックス・ラボラトリーズ・リミテッド

ページTOPに戻る

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Increase in R&D activities & government funding
3.5.1.2.Surge in adoption of multiplex assays to reduce operation costs
3.5.1.3.Rise in adoption of personalized medicines

3.5.2.Restraint

3.5.2.1.Lack of skilled labor/healthcare professionals

3.5.3.Opportunity

3.5.3.1.Various growth opportunities in emerging economies

3.6.COVID-19 impact analysis on multiplex assay market

CHAPTER 4:MULTIPLEX ASSAY MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Protein based multiplex assays

4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Nucleic Acid-Based Multiplex Assay

4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Other multiplex assays

4.4.1.Key market trends and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:MULTIPLEX ASSAY MARKET, BY PRODUCT

5.1.Overview

5.1.1.Market size and forecast

5.2.Reagents and Consumables

5.2.1.Key market trends and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Instruments and Accessories

5.3.1.Key market trends and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country

5.4.Software & Services

5.4.1.Key market trends and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country

CHAPTER 6:MULTIPLEX ASSAY MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Clinical Diagnostics

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Research and development

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Companion Diagnostics

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:MULTIPLEX ASSAY MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Hospitals

7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country

7.3.Clinical Laboratories

7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country

7.4.Research Institutes

7.4.1.Market size and forecast, by region
7.4.2.Market analysis, by country

7.5.Pharmaceutical & biotechnology companies

7.5.1.Market size and forecast, by region
7.5.2.Market analysis, by country

CHAPTER 8:MULTIPLEX ASSAY MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country

8.2.2.1.U.S.

8.2.2.1.1.U.S. Multiplex Assay Market, by type
8.2.2.1.2.U.S. Multiplex Assay Market, by product
8.2.2.1.3.U.S. Multiplex Assay Market, by application
8.2.2.1.4.U.S. Multiplex Assay Market, by end user

8.2.2.2.Canada

8.2.2.2.1.Canada Multiplex Assay Market, by type
8.2.2.2.2.Canada Multiplex Assay Market, by product
8.2.2.2.3.Canada Multiplex Assay Market, by application
8.2.2.2.4.Canada Multiplex Assay Market, by end user

8.2.2.3.Mexico

8.2.2.3.1.Mexico Multiplex Assay Market, by type
8.2.2.3.2.Mexico Multiplex Assay Market, by product
8.2.2.3.3.Mexico Multiplex Assay Market, by application
8.2.2.3.4.Mexico Multiplex Assay Market, by end user

8.2.3.North America market size and forecast, by type
8.2.4.North America market size and forecast, by product
8.2.5.North America market size and forecast, by application
8.2.6.North America market size and forecast, by end user

8.3.Europe

8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country

8.3.2.1.Germany

8.3.2.1.1.Germany Multiplex Assay Market, by type
8.3.2.1.2.Germany Multiplex Assay Market, by product
8.3.2.1.3.Germany Multiplex Assay Market, by application
8.3.2.1.4.Germany Multiplex Assay Market, by end user

8.3.2.2.France

8.3.2.2.1.France Multiplex Assay Market, by type
8.3.2.2.2.France Multiplex Assay Market, by product
8.3.2.2.3.France Multiplex Assay Market, by application
8.3.2.2.4.France Multiplex Assay Market, by end user

8.3.2.3.UK

8.3.2.3.1.UK Multiplex Assay Market, by type
8.3.2.3.2.UK Multiplex Assay Market, by product
8.3.2.3.3.UK Multiplex Assay Market, by application
8.3.2.3.4.UK Multiplex Assay Market, by end user

8.3.2.4.Italy

8.3.2.4.1.Italy Multiplex Assay Market, by type
8.3.2.4.2.Italy Multiplex Assay Market, by product
8.3.2.4.3.Italy Multiplex Assay Market, by application
8.3.2.4.4.Italy Multiplex Assay Market, by end user

8.3.2.5.Spain

8.3.2.5.1.Spain Multiplex Assay Market, by type
8.3.2.5.2.Spain Multiplex Assay Market, by product
8.3.2.5.3.Spain Multiplex Assay Market, by application
8.3.2.5.4.Spain Multiplex Assay Market, by end user

8.3.2.6.Rest of Europe

8.3.2.6.1.Rest of Europe Multiplex Assay Market, by type
8.3.2.6.2.Rest of Europe Multiplex Assay Market, by product
8.3.2.6.3.Rest of Europe Multiplex Assay Market, by application
8.3.2.6.4.Rest of Europe Multiplex Assay Market, by end user

8.3.3.Europe market size and forecast, by type
8.3.4.Europe market size and forecast, by product
8.3.5.Europe market size and forecast, by application
8.3.6.Europe market size and forecast, by end user

8.4.Asia-Pacific

8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country

8.4.2.1.Japan

8.4.2.1.1.Japan Multiplex Assay Market, by type
8.4.2.1.2.Japan Multiplex Assay Market, by product
8.4.2.1.3.Japan Multiplex Assay Market, by application
8.4.2.1.4.Japan Multiplex Assay Market, by end user

8.4.2.2.China

8.4.2.2.1.China Multiplex Assay Market, by type
8.4.2.2.2.China Multiplex Assay Market, by product
8.4.2.2.3.China Multiplex Assay Market, by application
8.4.2.2.4.China Multiplex Assay Market, by end user

8.4.2.3.Australia

8.4.2.3.1.Australia Multiplex Assay Market, by type
8.4.2.3.2.Australia Multiplex Assay Market, by product
8.4.2.3.3.Australia Multiplex Assay Market, by application
8.4.2.3.4.Australia Multiplex Assay Market, by end user

8.4.2.4.India

8.4.2.4.1.India Multiplex Assay Market, by type
8.4.2.4.2.India Multiplex Assay Market, by product
8.4.2.4.3.India Multiplex Assay Market, by application
8.4.2.4.4.India Multiplex Assay Market, by end user

8.4.2.5.Rest of Asia-Pacific

8.4.2.5.1.Rest of Asia-Pacific Multiplex Assay Market, by type
8.4.2.5.2.Rest of Asia-Pacific Multiplex Assay Market, by product
8.4.2.5.3.Rest of Asia-Pacific Multiplex Assay Market, by application
8.4.2.5.4.Rest of Asia-Pacific Multiplex Assay Market, by end user

8.4.3.Asia-Pacific market size and forecast, by type
8.4.4.Asia-Pacific market size and forecast, by product
8.4.5.Asia-Pacific market size and forecast, by application
8.4.6.Asia-Pacific market size and forecast, by end user

8.5.LAMEA

8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country

8.5.2.1.Brazil

8.5.2.1.1.Brazil Multiplex Assay Market, by type
8.5.2.1.2.Brazil Multiplex Assay Market, by product
8.5.2.1.3.Brazil Multiplex Assay Market, by application
8.5.2.1.4.Brazil Multiplex Assay Market, by end user

8.5.2.2.Saudi Arabia

8.5.2.2.1.Saudi Arabia Multiplex Assay Market, by type
8.5.2.2.2.Saudi Arabia Multiplex Assay Market, by product
8.5.2.2.3.Saudi Arabia Multiplex Assay Market, by application
8.5.2.2.4.Saudi Arabia Multiplex Assay Market, by end user

8.5.2.3.South Africa

8.5.2.3.1.South Africa Multiplex Assay Market, by type
8.5.2.3.2.South Africa Multiplex Assay Market, by product
8.5.2.3.3.South Africa Multiplex Assay Market, by application
8.5.2.3.4.South Africa Multiplex Assay Market, by end user

8.5.2.4.Rest of LAMEA

8.5.2.4.1.Rest of LAMEA Multiplex Assay Market, by type
8.5.2.4.2.Rest of LAMEA Multiplex Assay Market, by product
8.5.2.4.3.Rest of LAMEA Multiplex Assay Market, by application
8.5.2.4.4.Rest of LAMEA Multiplex Assay Market, by end user

8.5.3.LAMEA market size and forecast, by type
8.5.4.LAMEA market size and forecast, by product
8.5.5.LAMEA market size and forecast, by application
8.5.6.LAMEA market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES

9.1.ABCAM PLC.

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.BECTON, DICKINSON, AND COMPANY (BD BIOSCIENCES)

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments

9.3.MESO SCALE DIAGNOSTICS LLC

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio

9.4.SEEGENE INC.

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio

9.5.BIO-RAD LABORATORIES, INC.

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments

9.6.ILLUMINA, INC.

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments

9.7.QIAGEN N.V.

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.THERMO FISHER SCIENTIFIC, INC.

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments

9.9.LUMINEX CORPORATION

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments

9.10.RANDOX LABORATORIES LTD.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio

List of Tables

LIST OF TABLES

TABLE 01.MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 02.MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY REGION, 2020–2030 ($MILLION)
TABLE 03.MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAY, BY REGION, 2020–2030 ($MILLION)
TABLE 04.MULTIPLEX ASSAY MARKET FOR OTHER MULTIPLEX ASSAYS, BY REGION, 2020–2030 ($MILLION)
TABLE 05.MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 06.MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY REGION, 2020–2030 ($MILLION)
TABLE 07.MULTIPLEX ASSAY MARKET FOR INSTRUMENTS & ACCESSORIES, BY REGION, 2020–2030 ($MILLION)
TABLE 08.MULTIPLEX ASSAY MARKET FOR SOFTWARE & SERVICES, BY REGION, 2020–2030 ($MILLION)
TABLE 09.MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 10.MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2020–2030 ($MILLION)
TABLE 11.MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY REGION, 2020–2030 ($MILLION)
TABLE 12.MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY REGION, 2020–2030 ($MILLION)
TABLE 13.MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 14.MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY REGION, 2020–2030 ($MILLION)
TABLE 15.MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY REGION, 2020–2030 ($MILLION)
TABLE 16.MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY REGION, 2020–2030 ($MILLION)
TABLE 17.MULTIPLEX ASSAY MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2030 ($MILLION)
TABLE 18.MULTIPLEX ASSAY MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 19.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 20.U.S. MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 21.U.S. MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 22.U.S. MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 23.U.S. MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 24.CANADA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 25.CANADA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 26.CANADA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 27.CANADA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 28.MEXICO MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 29.MEXICO MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 30.MEXICO MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 31.MEXICO MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 32.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 33.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 34.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35.NORTH AMERICA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36.EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 37.GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 38.GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 39.GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 40.GERMANY MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 41.FRANCE MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 42.FRANCE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 43.FRANCE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 44.FRANCE MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45.UK MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 46.UK MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 47.UK MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 48.UK MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 49.ITALY MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 50.ITALY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 51.ITALY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 52.ITALY MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 53.SPAIN MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 54.SPAIN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 55.SPAIN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 56.SPAIN MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 57.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 58.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 59.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 60.REST OF EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61.EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 62.EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 63.EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 64.EUROPE MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 65.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 66.JAPAN MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 67.JAPAN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 68.JAPAN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 69.JAPAN MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70.CHINA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 71.CHINA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 72.CHINA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 73.CHINA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 74.AUSTRALIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 75.AUSTRALIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 76.AUSTRALIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 77.AUSTRALIA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 78.INDIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 79.INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 80.INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 81.INDIA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 82.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 83.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 84.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 85.REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 87.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 88.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 89.ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 90.LAMEA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 91.BRAZIL MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 92.BRAZIL MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 93.BRAZIL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 94.BRAZIL MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 95.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 96.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 97.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 98.SAUDI ARABIA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 99.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 100.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 101.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 102.SOUTH AFRICA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 103.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 104.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 105.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 106.REST OF LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 107.LAMEA MULTIPLEX ASSAY MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 108.LAMEA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 109.LAMEA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 110.LAMEA MULTIPLEX ASSAY MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 111.ABCAM PLC.: COMPANY SNAPSHOT
TABLE 112.ABCAM PLC.: OPERATING SEGMENTS
TABLE 113.ABCAM PLC.: PRODUCT PORTFOLIO
TABLE 114.ABCAM PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 116.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 117.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 118.BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119.MESO SCALE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 120.MESO SCALE DIAGNOSTICS: OPERATING SEGMENTS
TABLE 121.MESO SCALE DIAGNOSTICS: PRODUCT PORTFOLIO
TABLE 122.SEEGENE: COMPANY SNAPSHOT
TABLE 123.SEEGENE: OPERATING SEGMENTS
TABLE 124.SEEGENE: PRODUCT PORTFOLIO
TABLE 125.BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 126.BIO-RAD LABORATORIES: OPERATING SEGMENTS
TABLE 127.BIO-RAD LABORATORIES: PRODUCT PORTFOLIO
TABLE 128.BIO-RAD LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129.ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 130.ILLUMINA INC.: OPERATING SEGMENTS
TABLE 131.ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 132.ILLUMINA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 133.QIAGEN: COMPANY SNAPSHOT
TABLE 134.QIAGEN NV: OPERATING SEGMENTS
TABLE 135.QIAGEN NV: PRODUCT PORTFOLIO
TABLE 136.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 137.THERMO FISHER: COMPANY SNAPSHOT
TABLE 138.THERMO FISHER: OPERATING SEGMENTS
TABLE 139.THERMO FISHER: PRODUCT PORTFOLIO
TABLE 140.THERMO FISHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 141.LUMINEX CORPORATION: COMPANY SNAPSHOT
TABLE 142.LUMINEX CORPORATION: OPERATING SEGMENTS
TABLE 143.LUMINEX CORPORATION: PRODUCT PORTFOLIO
TABLE 144.LUMINEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 145.RANDOX: COMPANY SNAPSHOT
TABLE 146.RANDOX OPERATING SEGMENTS
TABLE 147.RANDOX: PRODUCT PORTFOLIO

List of Figures

LIST OF FIGURES

FIGURE 01.MULTIPLEX ASSAY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS, 2020
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019–2021
FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.LOW THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PROTEIN BASED MULTIPLEX ASSAYS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 13.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR NUCLEIC ACID-BASED MULTIPLEX ASSAY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR OTHER MULTIPLEX ASSAYS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR REAGENTS AND CONSUMABLES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH AND DEVELOPMENT, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR COMPANION DIAGNOSTICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF MULTIPLEX ASSAY MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 25.ABCAM PLC.: NET SALES, 2018–2020 ($ MILLION)
FIGURE 26.ABCAM PLC. REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 27.BECTON, DICKINSON AND COMPANY: NET SALES, 2018–2020 ($ MILLION)
FIGURE 28.BECTON, DICKINSON AND COMPANY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29.BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 30.BIO-RAD LABORATORIES: NET SALES, 2018–2020 ($ MILLION)
FIGURE 31.BIO-RAD LABORATORIES: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 32.BIO-RAD LABORATORIES: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 33.ILLUMINA, INC.: NET SALES, 2018–2020 ($ MILLION)
FIGURE 34.ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35.ILLUMINA, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 36.QIAGEN NV: NET SALES, 2020–2030 ($ MILLION)
FIGURE 37.QIAGEN: REVENUE SHARE BY PRODUCT, 2020 (%)
FIGURE 38.QIAGEN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 39.THERMO FISHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 40.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 41.THERMO FISHER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 42.LUMINEX CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 43.LUMINEX CORPORATION: REVENUE SHARE BY REGION, 2020 (%)

ページTOPに戻る

Table of Contents

Summary

The global multiplex assay market was valued at $1,940.49 million in 2020, and is projected to reach $4,366.32 million by 2030, registering a CAGR of 8.3% from 2021 to 2030.
The multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others.
The multiplex assays market is witnessing tremendous growth owing to increase in R&D activities in pharmaceuticals for the treatment of several diseases. These assays are used in clinical trials as they decrease the cost of research & manual labor and increase the efficiency of experiments and therapies. In addition, they offer easier & faster analysis of diseases, and automated as compared to conventional methods, thus fueling the market growth. However, high capital investment and dearth of skilled labors are the major factors that hinder the market growth.

The global multiplex assays market in this report is studied based on type, product, application, end user, and region. On the basis of type, the market is divided protein based multiplex assays, nucleic acid-based multiplex assay, and other multiplex assays. By product, the market is classified into reagents & consumables, instruments & accessories, software & services.
The applications covered in the study include clinical diagnostics, research & development, and companion diagnostics. As per end user, the market is segregated into hospitals, clinical laboratories, research institutes, and pharmaceutical & biotechnology companies. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major factors driving the market are increasing use of multiplex assays in companion diagnostics, increasing advantages over singleplex and traditional assays, increasing incidence of chronic and infectious diseases, and growing awareness about early disease diagnosis. In addition, growing adoption of personalized medicine, and a wide range of advantages of multiplex assays over traditional assays are positively impacting the growth of the multiplex assay market.
However, dearth of skilled professionals is expected to create hindrances for the growth of the multiplex assay market. Moreover, high procurement and operational costs along with the cumbersome and complex nature of multiplex assay instruments remain a significant hurdle in the multiplex assay market.
Increasing validation of the biomarkers in molecular and protein diagnostics, along with the rising need of the high-throughput and automated systems which are creating lucrative opportunities in the multiplex assay market.
Region wise, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the multiplex assays market in 2020, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the increase in government funds for the detection of new biomarkers, rise in R&D activates of new drugs and diagnosis & treatment options, as well as surge in prevalence of chronic diseases such as cancer and strokes.
The major players operating in the global multiplex assays market are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Becton, Dickinson and Company, Abcam PLC, Seegene Inc., Meso Scale Diagnostics LLC, and Randox Laboratories Ltd. These players adopted product launch, collaboration, and merger & acquisition as their key developmental strategies.
KEY BENEFITS FOR STAKEHOLDERS
• The report provides in-depth analysis of the global multiplex assay market size along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
• A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global multiplex assay market growth.

KEY MARKET SEGMENTS
# By Type
##Protein-Based Multiplex Assays
##Nucleic Acid-Based Multiplex Assay
##Other multiplex Assays

# By Product
##Reagents & Consumables
##Instruments & Accessories
##Software & Services

#By application
##Clinical Diagnostics
##Research & Development
##Companion Diagnostics

#By End Users
##Hospitals
##Clinical Laboratories
##Research Institutes
##Pharmaceuticals & Biotechnological Companies

#By Region
##North America
###U.S.
###Canada
###Mexico
##Europe
###Germany
###France
###UK
###Italy
###Spain
###Rest of Europe
##Asia-Pacific
###Japan
###China
###Australia
###India
###South Korea
###Rest of Asia-Pacific
##LAMEA
###Brazil
###Saudi Arabia
###South Africa
###Rest of LAMEA

List of key players profiled in the report:
• Luminex Corporation
• Thermo Fisher Scientific Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Becton, Dickinson and Company
• Abcam PLC
• Seegene Inc.
• Meso Scale Diagnostics LLC
• Randox Laboratories Ltd.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオマス）の最新刊レポート

Allied Market Research社のバイオマス分野での最新刊レポート

本レポートと同じKEY WORD（assay）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオマス）の最新刊レポート

Allied Market Research社のバイオマス分野での最新刊レポート

本レポートと同じKEY WORD（assay）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?